ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1849–1860 of 2020 project topics
ATP1A2 Familial Hemiplegic Migraine Genetic Screening Kit
A direct-to-consumer and clinical genetic screening kit that detects ATP1A2 and CACNA1A pathogenic variants in familial hemiplegic migraine patients to enable personalized preventive therapy. The kit monetizes through direct sales, neurology clinic partnerships, and premium interpretation reports with lifestyle and medication recommendations.
Genetic Basis of Skeletal Muscle Channelopathies Click to view more details →
CACNB4 Episodic Ataxia Genetic Risk Stratification Engine
A proprietary genomic risk stratification engine that predicts phenotypic severity and treatment response in CACNB4-related episodic ataxia type 5 patients using variant-specific clinical data. The engine drives revenue through neurology center contracts, insurance pathway optimization programs, and integration with patient management platforms.
Genetic Basis of Skeletal Muscle Channelopathies Click to view more details →
MMACHC Cobalamin C Deficiency Testing
Developing MMACHC gene testing for the most common intracellular cobalamin disorder for molecular diagnosis and guiding hydroxocobalamin treatment.
Genetic Basis of Congenital Disorders of Cobalamin Metabolism Click to view more details →
MMADHC Cobalamin D and Combined CB Deficiency
Characterizing MMADHC variants causing methylmalonic aciduria, homocystinuria, and combined forms for molecular diagnosis.
Genetic Basis of Congenital Disorders of Cobalamin Metabolism Click to view more details →
Transcobalamin II Deficiency TCN2 Gene Testing
Identifying TCN2 variants causing transcobalamin II deficiency for molecular diagnosis in infants with megaloblastic anemia and failure to thrive.
Genetic Basis of Congenital Disorders of Cobalamin Metabolism Click to view more details →
Intrinsic Factor and Cobalamin Absorption Genetics
Testing GIF, CUBN, AMN, and LMBRD1 genes for diagnosing hereditary causes of cobalamin malabsorption in children with megaloblastic anemia.
Genetic Basis of Congenital Disorders of Cobalamin Metabolism Click to view more details →
MTHFR Methylenetetrahydrofolate Reductase Defect Detection Platform
A commercial genomic screening SaaS platform that identifies MTHFR mutations causing impaired cobalamin metabolism and folate cycle dysfunction in newborns. This tool enables prenatal and early postnatal diagnosis, creating recurring subscription revenue from diagnostic laboratories and genetic counseling centers.
Genetic Basis of Congenital Disorders of Cobalamin Metabolism Click to view more details →
Methylmalonic Aciduria Genetic Risk Stratification Commercial Service
An industry-leading genetic testing service that stratifies methylmalonic aciduria patients by MUT gene mutations and cobalamin metabolism defects to guide targeted treatment protocols. This specialized diagnostic offering generates premium revenue through direct-to-hospital partnerships and insurance reimbursement models.
Genetic Basis of Congenital Disorders of Cobalamin Metabolism Click to view more details →
Homocysteine Metabolism Gene Panel Analytics Dashboard
A proprietary bioinformatics platform delivering comprehensive analysis of genes controlling homocysteine metabolism linked to cobalamin deficiency disorders. The tool monetizes through per-sample processing fees and enterprise licensing agreements with major diagnostic and pharmaceutical companies.
Genetic Basis of Congenital Disorders of Cobalamin Metabolism Click to view more details →
CblE and CblG Cobalamin Synthesis Defect Targeted Testing Kit
A commercial direct-to-lab molecular testing kit focusing on CblE and CblG gene mutations that disrupt cobalamin adenosylation and methylation pathways. This specialized product generates high-margin revenue through volume-based purchasing agreements with regional and national reference laboratories.
Genetic Basis of Congenital Disorders of Cobalamin Metabolism Click to view more details →
Cobalamin Absorption Defects Early Detection Software Algorithm
An AI-powered software tool that predicts cobalamin absorption deficiency phenotypes by analyzing genetic variants in genes encoding transport proteins and gastric parietal cells. The platform drives revenue through SaaS licensing, integration fees with EHR systems, and clinical validation partnerships.
Genetic Basis of Congenital Disorders of Cobalamin Metabolism Click to view more details →
Newborn Screening Cobalamin Metabolism Gene Mutation Database Service
A commercial cloud-based variant interpretation database and clinical decision-support system for cobalamin metabolism genetic disorders used by newborn screening programs. This service generates ongoing subscription and per-query revenues while expanding market reach through state health department contracts and international licensing.
Genetic Basis of Congenital Disorders of Cobalamin Metabolism Click to view more details →